Tirzepatide: What Twelve Phase-3 Trials, the Large Late Tests, Found
Doctors prescribe tirzepatide as a shot. Here you'll read about sugar, body weight, unwanted effects, and the time each change took.
What Tirzepatide Changes in Your Body
Tirzepatide is a prescription shot used for some long-term health needs. Here is what it changed in the main studies. The shot joins 39-amino-acid pieces into one protein; amino acids are what proteins are made from [1]. A bit of fat added to the drug helps one shot last about five days [3].
Your gut releases the hormones called GIP and GLP-1 after a meal. GIP tells the pancreas to help lower blood sugar. Both GIP and GLP-1 help you feel full. Tirzepatide acts like GIP and GLP-1 [1]. In lab work, cells kept replying to the GLP-1 copy for longer [1]. That lab result is one reason the shot may keep working through the week, but a cell study can't predict your result.
Approval for type 2 diabetes came in May 2022. Approval for obesity followed in November 2023. Adults with obesity gained approval for sleep-apnea care in June 2024 [17].
What tirzepatide does when blood sugar rises
As blood sugar rises, the 39-amino-acid medicine draws more insulin from the pancreas. Six SURPASS trials studied blood sugar in type 2 diabetes. Four SURMOUNT trials studied weight. At your visit, I'd ask whether one of those approved uses fits your health.
What Tirzepatide Changed for Weight
The largest weight change came from SURMOUNT-1, a phase-3 trial, one of the big tests done near the end. The study followed 2,539 adults with extra weight or obesity, but without diabetes, in a 72-week study. The 5, 10, and 15 mg groups lost averages of 15.0%, 19.5%, and 20.9%. People given an inactive shot called a placebo lost 3.1% [7]. More than half at 10 mg and 15 mg lost at least 20% of their weight. At 15 mg, the upper blood-pressure number fell 7.2 millimeters of mercury. A pressure cuff uses that same unit. Triglycerides, one kind of fat in the blood, fell 24.8% [7].
SURMOUNT-2 followed 938 people who also had type 2 diabetes for 72 weeks. Average losses at 10 and 15 mg were 12.8% and 14.7%. The placebo group lost 3.2%. Among those taking tirzepatide, 79–83% lost at least 5% [8].
For people with type 2 diabetes, SURPASS-1 through -5 checked average blood sugar over several months. That blood-test result fell 1.87 to 2.59 points across the 5–15 mg range. Those were large falls. In one trial, 81–86% at 15 mg reached 6.5% or less [4].
When tirzepatide brought most of the weight loss
In SURMOUNT-1, people at 15 mg had lost about 5% by week 12. Most of the 20.9% average loss came between weeks 12 and 52. Weight was still falling at week 72 [7].
When tirzepatide first changed weight
The first clear change in SURMOUNT-1 appeared by week 12. People at 15 mg had lost about 5%. Most of the 20.9% loss came from weeks 12 through 52 [7]. Your own pace may differ.
Did a tirzepatide weight loss clinic program keep weight off?
Across the 72-week SURMOUNT studies, average loss was 15–21%, based on the amount used. In SURMOUNT-4, people stopped tirzepatide after 36 weeks. They regained 14.0% on average during the next 52 weeks [9]. The study can't promise that weight will stay off once the drug stops.
At your visit, you won't need every average, and you don't have to guess which finding matters for your health; this page can't decide that. Ask what your doctor will watch first, what won't apply to you, what isn't known, how your health changes the goal, and what can't be learned from one trial. If time is short, I'd begin with the finding you care about most for your daily life, but you can't skip the other risks; your own cost won't appear in a study, so the numbers can't tell you if long care will fit your budget. No average can promise your pace or tell you what happens after stopping; it isn't a plan for your care, and it can't account for your daily needs.
Why the Tirzepatide Studies Raised the Amount Slowly
The studies began tirzepatide at 2.5 mg as a weekly shot. After the first four weeks, the amount rose by 2.5 mg every four weeks, up to 15 mg [17]. That made six steps: 2.5, 5, 7.5, 10, 12.5, and 15 mg. The first 2.5 mg step gave the stomach time to adjust. It wasn't the long-term study amount.
The three long-term amounts were 5, 10, and 15 mg each week. Each beat placebo for weight and blood sugar. The largest weight and long-term blood-sugar changes came at 15 mg [4][7]. Study amounts don't set your care.
The page on how the study amount rose covers stomach trouble, surgery, and other drugs. Those are useful topics for your next visit.
What Tirzepatide Changed Besides Weight
Across SURPASS, the upper blood-pressure number fell 4.2 to 12.6 millimeters of mercury. In SURPASS-4, tirzepatide lowered that number more than a long-lasting insulin shot called insulin glargine. Weight loss explained part of the difference. Another 33–57% of that extra drop came from something else [12]. A heart study followed 13,299 people with heart disease and type 2 diabetes for about four years. Its main 3 problems were death from heart disease, heart attack, and stroke. Tirzepatide didn't cause more of them than dulaglutide, a once-a-week diabetes shot. A later check found fewer deaths from any cause with tirzepatide [14].
SURMOUNT-OSA (2024) studied people with sleep apnea and obesity in two large trials. Breathing pauses fell by about 25 and 29 events per hour. Placebo groups improved by 5–6 events per hour over 52 weeks [13]. Approval for this use came in June 2024 [17].
When tirzepatide began to work in studies
In SURMOUNT-1, weight had changed by week 12. In SURPASS-2, the several-month blood-sugar test fell more than 1 point within 4 weeks at 5 mg [5]. Your visit can focus on the change that matters most to you.
Which Tirzepatide Question Do You Want Answered?
Your next step depends on the question you want to bring to a visit.
What does the shot change? — The gut makes two hormones that change hunger and the way your body handles sugar. One is called GLP-1. Lab work from 2020 and 2022 helps explain what the shot copies. Read what tirzepatide does in the body and why it copies both hormones from the gut.
Why did the study amount rise slowly? — The trials moved from 2.5-to-15 mg in steps. Learn why they waited and when stomach trouble was most common. Read how the tirzepatide study amount rose.
How did two weekly shots compare? — SURPASS-2 tested tirzepatide against semaglutide 1 mg, another diabetes shot. The same page covers the heart and sleep-apnea studies. Read the tirzepatide vs semaglutide study result.
What can happen over time? — SURMOUNT-4 followed weight after people stopped. The common questions page gives 28 short answers on side effects, the thyroid warning, and what the trials can't tell you.